1. A blood cell analyzer comprising:
a detector for detecting first and second light information from leukocytes contained in a specimen of a subject; and
a controller, including a memory under the control of a processor, the memory storing:
correlation information relating to the correlation between inflammation-related marker measurement data and leukocyte distribution data; and
instructions enabling the processor to carry out operations, comprising:
(a) generating leukocyte distribution data for classifying the leukocytes to subclasses, the leukocyte distribution data including a two dimensional distribution on which the leukocytes in the specimen are plotted according to the detected first and second light information;
(b) obtaining the inflammation-related marker measurement data based on the correlation information and the leukocyte distribution data of the subject; and
(c) outputting the obtained inflammation-related marker measurement data.
2. The blood cell analyzer of claim 1, wherein the operations further comprise:
(d) classifying the leukocyte distribution data in a plurality of categories; and
(e) storing, in the memory, the correlation information of the inflammation-related marker measurement data and the distribution data of the leukocytes classified in the plurality of categories.
3. The blood cell analyzer of claim 2, wherein the operations further comprise:
(f) classifying the leukocyte distribution data in a plurality of categories; and
wherein step (b) comprises obtaining the inflammation-related marker measurement data based on the correlation information and the distribution data classified in the plurality of categories.
4. The blood cell analyzer of claim 3, wherein
the correlation information is a multiple regression function h of the inflammation-related marker measurement data Ck and the distribution data xki (1=1, 2, . . . s) of the plurality of micro regions, calculated based on the obtained inflammation-related marker measurement data Ck and the distribution data xki (i=1, 2, . . . s) of a plurality of micro regions converted from the leukocyte distribution data Xk (k=1, 2, . . . n); and
step (b) comprises calculating, via equation (3), the obtained measurement data of the inflammation-related marker based on the multiple regression function h and the micro region distribution data xi converted from the leukocyte distribution data of the subject.
B=g(x1, x2, . . . , xi, . . . , xs) Eq. (3)
5. The blood cell analyzer of claim 3, wherein
the correlation information is multiple regression functions c0 and ci calculated by executing linear multiple regression analysis based on the obtained inflammation-related marker measurement data Ck and the distribution data xki (i=1, 2, . . . s) of the plurality of micro regions converted from the leukocyte distribution data Xk (k=1, 2, . . . n); and
step (b) comprises calculating, via equation (4), the obtained measurement data of the inflammation-related marker based on the multiple regression functions co and ci and the distribution data xi of the plurality of micro regions converted form the leukocyte distribution data X of the subject
C
=
\u2211
i
=
1
s
\u2062
\u2062
c
\u2062
\u2062
i
\xb7
x
\u2062
\u2062
i
+
c
\u2062
\u2062
0
Equation
\u2062
\u2062
(
4
)
6. The blood cell analyzer of claim 1, wherein
the inflammation-related marker is any among c-reactive protein, serum amyloid A, and reticulocyte sedimentation rate.
7. The blood cell analyzer of claim 1, wherein
the inflammation-related marker is c-reactive protein, and the obtained measurement data of the inflammation-related marker are measurement data of the c-reactive protein after several days have elapsed.
8. The blood cell analyzer of claim 1, wherein the step (b) comprises:
(d) dividing the two dimensional distribution into a plurality of regions;
(e) converting the distribution of plots in each of the regions into values; and
(f) applying the values with a predefined function which defines a relationship of the values and the inflammation-related marker measurement data.
9. The blood cell analyzer of claim 1, further comprising a sample preparing section which prepares a specimen containing a fluorescence dye and a blood sample.
10. The blood cell analyzer of claim 9, wherein the detector is configured to irradiate leukocytes with light and to detect scattered light and fluorescence from the leukocytes, and wherein the first light information is an intensity of the detected scattered light and the second light information is an intensity of the detected fluorescence.
11. A blood cell analyzing method comprising:
(a) generating leukocyte distribution data for classifying leukocytes to subclasses, the leukocyte distribution data including a two dimensional distribution on which the leukocytes in a specimen are plotted according to first and second light information which is detectable from leukocytes;
(b) obtaining inflammation-related marker measurement data based on correlation information and the leukocyte distribution data, the correlation information relating to the correlation between inflammation-related marker measurement data and the leukocyte distribution data; and
(c) outputting the obtained inflammation-related marker measurement data.
12. A computer program product, comprising:
a computer readable medium; and
instructions, on the computer readable medium, adapted to enable a general purpose computer to perform operations, comprising:
(a) generating leukocyte distribution data for classifying leukocytes to subclasses, the leukocyte distribution data including a two dimensional distribution on which the leukocytes in a specimen are plotted according to first and second light information which is detectable from leukocytes;
(b) obtaining inflammation-related marker measurement data based on correlation information and leukocyte distribution data, the correlation information relating to the correlation between inflammation-related marker measurement data and the leukocyte distribution data; and
(c) outputting the obtained inflammation-related marker measurement data.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A substrate-HSQ resist material, in which the substrate is selected from germanium or gallium arsenide, suitable for use in nanodevice fabrication and comprising a germanium or gallium arsenide substrate having a surface bearing a high resolution HSQ resist film or layer, in which the substrate has a halogen terminated surface.
2. The material as claimed in claim 1 in which the germanium substrate is doped or undoped germanium or an alloy thereof.
3. The material as claimed in claim 1 in which the gallium arsenide substrate is doped or undoped gallium arsenide or an alloy thereof.
4. The material as claimed in claim 1 in which the halogen is chlorine.
5. A nanoimprinted germanium or gallium arsenide substrate having a halogen-terminated surface bearing EBL-formed or EUV-formed nanostructures having a sub-1OO nm resolution.
6. The nanoimprinted germanium or gallium arsenide substrate of claim 5 bearing EBL-formed or EUV-formed nanostructures having a sub-20 nm resolution.
7. The nanoimprinted germanium substrate of claim 5 having a chlorine terminated germanium surface.
8. The nanodevice comprising a nanoimprinted germanium substrate of claim 5.
9. A method of fabricating a substrate-HSQ resist material in which the substrate is selected from germanium (Ge) or gallium arsenide (GaAs), the method comprising the steps of pretreating a surface of the substrate to provide halogen termination of the substrate surface such that surface oxide is removed, and applying a HSQ resist to the surface.
10. The method as claimed in claim 9 in which the substrate is a germanium substrate.
11. The method as claimed in claim 9 in which the halogen is chlorine.
12. The method of fabricating a nanostructurenanofeature on a substrate selected from germanium (Ge) or gallium arsenide (GaAs) the method comprising the steps of fabricating a Ge or GaAs substrate-HSQ resist material according to claim 9, exposing the HSQ resist using litographic patterning, developing the exposed or unexposed regions of the HSQ with an aqueous developing agent, and transferring a pattern of nanostructuresnanofeatures formed in the preceeding steps on to the substrate.
13. The method of claim 12 in which the lithographic patterning is electron beam lithography (EBL) or extreme UV lithography (EUV).
14. The method as claimed in claim 9 in which the surface pretreatment step comprises the steps of: a first aqueous wash to remove surface dioxide; oxiding the underlying surface monoxide to provide an even layer of surface dioxide, and a final step of removing surface dioxide and providing surface halogen termination.
15. The method as claimed in claim 14 in which the substrate is germanium, and in which the surface pretreatment step comprises the steps of: a first aqueous wash to remove a layer of surface germanium dioxide; a step of oxiding the underlying surface germanium monoxide to provide an even layer of surface germanium dioxide, and a final step of removing surface dioxide and providing surface halogen termination.
16. A method of fabricating a nanopatterned germanium (Ge) or gallium arsenide (GaAs) substrate comprises the steps of depositing a HSQ film on a halogen terminated Ge or GaAs substrate, and generating a nanopattern on the substrate by nanoimprint lithography.
17. The substrate bearing a pattern of nanostructuresnanofeatures fabricated according to a method of claim 12.
18. The method as claimed in claim 12 in which the surface pretreatment step comprises the steps of: a first aqueous wash to remove surface dioxide; oxiding the underlying surface monoxide to provide an even layer of surface dioxide, and a final step of removing surface dioxide and providing surface halogen termination.
19. The method as claimed in claim 18 in which the substrate is germanium, and in which the surface pretreatment step comprises the steps of: a first aqueous wash to remove a layer of surface germanium dioxide; a step of oxiding the underlying surface germanium monoxide to provide an even layer of surface germanium dioxide, and a final step of removing surface dioxide and providing surface halogen termination.
20. The substrate bearing a pattern of nanostructuresnanofeatures fabricated according to a method of claim 16.